SenesTech shares surge 15.14% intraday after Evolve approved in New Zealand, aligning with Predator Free 2050 initiative and initial shipment to distributor.

SenesTech Inc. (SNES) surged 15.14% intraday after announcing that its Evolve rodent fertility control product received regulatory approval in New Zealand from the Ministry for Primary Industries. The approval aligns with New Zealand’s Predator Free 2050 initiative, a $4.5 billion conservation program aiming to eradicate invasive predators. SenesTech’s exclusive distributor, Evicom, has already received an initial stocking shipment, and the company emphasized the product’s role in offering a non-lethal, environmentally sustainable alternative to traditional rodenticides. CEO Joel Fruendt highlighted the strategic significance of entering a high-growth market with evolving regulatory demands, reinforcing the company’s position as a global leader in fertility control solutions. The news catalyzed immediate market optimism, reflecting confidence in expanded revenue opportunities and alignment with international conservation priorities.